目次

Table of Contents

1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Competitive landscape

2 Introduction
2.1. What is this report about?
2.2. Who is the target reader?
2.3. How to use this report
2.4. Definitions

3 Global Pharmaceuticals
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis

4 Macroeconomic Indicators
4.1. Country data

5 Pharmaceuticals in Asia-Pacific
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis

6 Pharmaceuticals in Europe
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis

7 Macroeconomic Indicators
7.1. Country data

8 Pharmaceuticals in France
8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis

9 Macroeconomic Indicators
9.1. Country data

10 Pharmaceuticals in Germany
10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis

11 Macroeconomic Indicators
11.1. Country data

12 Pharmaceuticals in Australia
12.1. Market Overview
12.2. Market Data
12.3. Market Segmentation
12.4. Market outlook
12.5. Five forces analysis

13 Macroeconomic Indicators
13.1. Country data

14 Pharmaceuticals in Brazil
14.1. Market Overview
14.2. Market Data
14.3. Market Segmentation
14.4. Market outlook
14.5. Five forces analysis

15 Macroeconomic Indicators
15.1. Country data

16 Pharmaceuticals in Canada
16.1. Market Overview
16.2. Market Data
16.3. Market Segmentation
16.4. Market outlook
16.5. Five forces analysis

17 Macroeconomic Indicators
17.1. Country data

18 Pharmaceuticals in China
18.1. Market Overview
18.2. Market Data
18.3. Market Segmentation
18.4. Market outlook
18.5. Five forces analysis

19 Macroeconomic Indicators
19.1. Country data

20 Pharmaceuticals in India
20.1. Market Overview
20.2. Market Data
20.3. Market Segmentation
20.4. Market outlook
20.5. Five forces analysis

21 Macroeconomic Indicators
21.1. Country data

22 Pharmaceuticals in Indonesia
22.1. Market Overview
22.2. Market Data
22.3. Market Segmentation
22.4. Market outlook
22.5. Five forces analysis

23 Macroeconomic Indicators
23.1. Country data

24 Pharmaceuticals in Italy
24.1. Market Overview
24.2. Market Data
24.3. Market Segmentation
24.4. Market outlook
24.5. Five forces analysis

25 Macroeconomic Indicators
25.1. Country data

26 Pharmaceuticals in Japan
26.1. Market Overview
26.2. Market Data
26.3. Market Segmentation
26.4. Market outlook
26.5. Five forces analysis

27 Macroeconomic Indicators
27.1. Country data

28 Pharmaceuticals in Mexico
28.1. Market Overview
28.2. Market Data
28.3. Market Segmentation
28.4. Market outlook
28.5. Five forces analysis

29 Macroeconomic Indicators
29.1. Country data

30 Pharmaceuticals in The Netherlands
30.1. Market Overview
30.2. Market Data
30.3. Market Segmentation
30.4. Market outlook
30.5. Five forces analysis

31 Macroeconomic Indicators
31.1. Country data

32 Pharmaceuticals in North America
32.1. Market Overview
32.2. Market Data
32.3. Market Segmentation
32.4. Market outlook
32.5. Five forces analysis

33 Pharmaceuticals in Russia
33.1. Market Overview
33.2. Market Data
33.3. Market Segmentation
33.4. Market outlook
33.5. Five forces analysis

34 Macroeconomic Indicators
34.1. Country data

35 Pharmaceuticals in Scandinavia
35.1. Market Overview
35.2. Market Data
35.3. Market Segmentation
35.4. Market outlook
35.5. Five forces analysis

36 Pharmaceuticals in Singapore
36.1. Market Overview
36.2. Market Data
36.3. Market Segmentation
36.4. Market outlook
36.5. Five forces analysis

37 Macroeconomic Indicators
37.1. Country data

38 Pharmaceuticals in South Africa
38.1. Market Overview
38.2. Market Data
38.3. Market Segmentation
38.4. Market outlook
38.5. Five forces analysis

39 Macroeconomic Indicators
39.1. Country data

40 Pharmaceuticals in South Korea
40.1. Market Overview
40.2. Market Data
40.3. Market Segmentation
40.4. Market outlook
40.5. Five forces analysis

41 Macroeconomic Indicators
41.1. Country data

42 Pharmaceuticals in Spain
42.1. Market Overview
42.2. Market Data
42.3. Market Segmentation
42.4. Market outlook
42.5. Five forces analysis

43 Macroeconomic Indicators
43.1. Country data

44 Pharmaceuticals in Turkey
44.1. Market Overview
44.2. Market Data
44.3. Market Segmentation
44.4. Market outlook
44.5. Five forces analysis

45 Macroeconomic Indicators
45.1. Country data

46 Pharmaceuticals in The United Kingdom
46.1. Market Overview
46.2. Market Data
46.3. Market Segmentation
46.4. Market outlook
46.5. Five forces analysis

47 Macroeconomic Indicators
47.1. Country data

48 Pharmaceuticals in The United States
48.1. Market Overview
48.2. Market Data
48.3. Market Segmentation
48.4. Market outlook
48.5. Five forces analysis

49 Macroeconomic Indicators
49.1. Country data

50 Company Profiles
50.1. Johnson & Johnson
50.2. Bayer AG
50.3. Laboratoires Pierre Fabre SA
50.4. Boehringer Ingelheim GmbH
50.5. Ache Laboratorios Farmaceuticos SA
50.6. Hypera SA
50.7. EMS Sigma Pharma
50.8. Apotex, Inc.
50.9. Yangtze River Pharmaceutical Group
50.10. Shanghai Pharmaceuticals Holding Co Ltd
50.11. Yunnan Baiyao Group Co Ltd
50.12. Guangzhou Pharmaceutical Holdings Ltd
50.13. Sun Pharmaceutical Industries Ltd
50.14. Lupin Ltd
50.15. Aurobindo Pharma Ltd
50.16. Dr. Reddy's Laboratories Limited
50.17. PT Kimia Farma Tbk
50.18. A Menarini Industrie Farmaceutiche Riunite Srl
50.19. Chiesi Farmaceutici SpA
50.20. Recordati S.p.A.
50.21. Daiichi Sankyo Co Ltd
50.22. Takeda Pharmaceutical Company Limited
50.23. Mitsubishi Tanabe Pharma Corporation
50.24. Les Laboratoires Servier
50.25. F. Hoffmann-La Roche Ltd
50.26. Astellas Pharma Inc.
50.27. Adcock Ingram Holdings Ltd
50.28. Aspen Pharmacare Holdings Ltd
50.29. Chong Kun Dang Pharmaceutical Corporation
50.30. Daewoong Pharmaceutical Co Ltd
50.31. Hanmi Pharmaceuticals Co Ltd
50.32. Almirall S.A.
50.33. Laboratorios Farmaceuticos ROVI, S.A.
50.34. Sanofi SA
50.35. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
50.36. Novartis AG
50.37. GSK plc.
50.38. Pfizer Inc.
50.39. Merck & Co., Inc.
50.40. AstraZeneca PLC

51 Appendix
51.1. Methodology
51.2. About MarketLine

List of Tables
Table 1: Global pharmaceuticals market value: $ billion, 2016-21
Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2021
Table 3: Global pharmaceuticals market share: % share, by value, 2021
Table 4: Global pharmaceuticals market value forecast: $ billion, 2021-26
Table 5: Global size of population (million), 2017-21
Table 6: Global gdp (constant 2005 prices, $ billion), 2017-21
Table 7: Global gdp (current prices, $ billion), 2017-21
Table 8: Global inflation, 2017-21
Table 9: Global consumer price index (absolute), 2017-21
Table 10: Global exchange rate, 2017-21
Table 11: Asia-Pacific pharmaceuticals market value: $ billion, 2016-21
Table 12: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2021
Table 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2021
Table 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2021-26
Table 15: Europe pharmaceuticals market value: $ billion, 2016-21
Table 16: Europe pharmaceuticals market geography segmentation: $ billion, 2021
Table 17: Europe pharmaceuticals market share: % share, by value, 2021
Table 18: Europe pharmaceuticals market value forecast: $ billion, 2021-26
Table 19: Europe size of population (million), 2017-21
Table 20: Europe gdp (constant 2005 prices, $ billion), 2017-21
Table 21: Europe gdp (current prices, $ billion), 2017-21
Table 22: Europe inflation, 2017-21
Table 23: Europe consumer price index (absolute), 2017-21
Table 24: Europe exchange rate, 2017-21
Table 25: France pharmaceuticals market value: $ billion, 2016-21
Table 26: France pharmaceuticals market geography segmentation: $ billion, 2021
Table 27: France pharmaceuticals market share: % share, by value, 2021
Table 28: France pharmaceuticals market value forecast: $ billion, 2021-26
Table 29: France size of population (million), 2017-21
Table 30: France gdp (constant 2005 prices, $ billion), 2017-21
Table 31: France gdp (current prices, $ billion), 2017-21
Table 32: France inflation, 2017-21
Table 33: France consumer price index (absolute), 2017-21
Table 34: France exchange rate, 2017-21
Table 35: Germany pharmaceuticals market value: $ billion, 2016-21
Table 36: Germany pharmaceuticals market geography segmentation: $ billion, 2021
Table 37: Germany pharmaceuticals market share: % share, by value, 2021
Table 38: Germany pharmaceuticals market value forecast: $ billion, 2021-26
Table 39: Germany size of population (million), 2017-21
Table 40: Germany gdp (constant 2005 prices, $ billion), 2017-21
Table 41: Germany gdp (current prices, $ billion), 2017-21
Table 42: Germany inflation, 2017-21
Table 43: Germany consumer price index (absolute), 2017-21
Table 44: Germany exchange rate, 2017-21
Table 45: Australia pharmaceuticals market value: $ billion, 2016-21
Table 46: Australia pharmaceuticals market geography segmentation: $ billion, 2021
Table 47: Australia pharmaceuticals market share: % share, by value, 2021
Table 48: Australia pharmaceuticals market value forecast: $ billion, 2021-26
Table 49: Australia size of population (million), 2017-21
Table 50: Australia gdp (constant 2005 prices, $ billion), 2017-21
Table 51: Australia gdp (current prices, $ billion), 2017-21
Table 52: Australia inflation, 2017-21
Table 53: Australia consumer price index (absolute), 2017-21
Table 54: Australia exchange rate, 2017-21
Table 55: Brazil pharmaceuticals market value: $ billion, 2016-21
Table 56: Brazil pharmaceuticals market geography segmentation: $ billion, 2021
Table 57: Brazil pharmaceuticals market share: % share, by value, 2021
Table 58: Brazil pharmaceuticals market value forecast: $ billion, 2021-26
Table 59: Brazil size of population (million), 2017-21
Table 60: Brazil gdp (constant 2005 prices, $ billion), 2017-21
Table 61: Brazil gdp (current prices, $ billion), 2017-21
Table 62: Brazil inflation, 2017-21
Table 63: Brazil consumer price index (absolute), 2017-21
Table 64: Brazil exchange rate, 2017-21
Table 65: Canada pharmaceuticals market value: $ billion, 2016-21
Table 66: Canada pharmaceuticals market geography segmentation: $ billion, 2021
Table 67: Canada pharmaceuticals market share: % share, by value, 2021
Table 68: Canada pharmaceuticals market value forecast: $ billion, 2021-26
Table 69: Canada size of population (million), 2017-21
Table 70: Canada gdp (constant 2005 prices, $ billion), 2017-21
Table 71: Canada gdp (current prices, $ billion), 2017-21
Table 72: Canada inflation, 2017-21
Table 73: Canada consumer price index (absolute), 2017-21
Table 74: Canada exchange rate, 2017-21
Table 75: China pharmaceuticals market value: $ billion, 2016-21
Table 76: China pharmaceuticals market geography segmentation: $ billion, 2021
Table 77: China pharmaceuticals market share: % share, by value, 2021
Table 78: China pharmaceuticals market value forecast: $ billion, 2021-26
Table 79: China size of population (million), 2017-21
Table 80: China gdp (constant 2005 prices, $ billion), 2017-21
Table 81: China gdp (current prices, $ billion), 2017-21
Table 82: China inflation, 2017-21
Table 83: China consumer price index (absolute), 2017-21
Table 84: China exchange rate, 2017-21
Table 85: India pharmaceuticals market value: $ billion, 2016-21
Table 86: India pharmaceuticals market geography segmentation: $ billion, 2021
Table 87: India pharmaceuticals market share: % share, by value, 2021
Table 88: India pharmaceuticals market value forecast: $ billion, 2021-26
Table 89: India size of population (million), 2017-21
Table 90: India gdp (constant 2005 prices, $ billion), 2017-21

List of Figures
Figure 1: Global pharmaceuticals market value: $ billion, 2016-21
Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 3: Global pharmaceuticals market share: % share, by value, 2021
Figure 4: Global pharmaceuticals market value forecast: $ billion, 2021-26
Figure 5: Forces driving competition in the global pharmaceuticals market, 2021
Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2021
Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2021
Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2021
Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2021
Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2021
Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2016-21
Figure 12: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2021
Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2021-26
Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2021
Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2021
Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2021
Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2021
Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2021
Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2021
Figure 21: Europe pharmaceuticals market value: $ billion, 2016-21
Figure 22: Europe pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 23: Europe pharmaceuticals market share: % share, by value, 2021
Figure 24: Europe pharmaceuticals market value forecast: $ billion, 2021-26
Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2021
Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2021
Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2021
Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2021
Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2021
Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2021
Figure 31: France pharmaceuticals market value: $ billion, 2016-21
Figure 32: France pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 33: France pharmaceuticals market share: % share, by value, 2021
Figure 34: France pharmaceuticals market value forecast: $ billion, 2021-26
Figure 35: Forces driving competition in the pharmaceuticals market in France, 2021
Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2021
Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2021
Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2021
Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2021
Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2021
Figure 41: Germany pharmaceuticals market value: $ billion, 2016-21
Figure 42: Germany pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 43: Germany pharmaceuticals market share: % share, by value, 2021
Figure 44: Germany pharmaceuticals market value forecast: $ billion, 2021-26
Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2021
Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2021
Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2021
Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2021
Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2021
Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2021
Figure 51: Australia pharmaceuticals market value: $ billion, 2016-21
Figure 52: Australia pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 53: Australia pharmaceuticals market share: % share, by value, 2021
Figure 54: Australia pharmaceuticals market value forecast: $ billion, 2021-26
Figure 55: Forces driving competition in the pharmaceuticals market in Australia, 2021
Figure 56: Drivers of buyer power in the pharmaceuticals market in Australia, 2021
Figure 57: Drivers of supplier power in the pharmaceuticals market in Australia, 2021
Figure 58: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2021
Figure 59: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2021
Figure 60: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2021
Figure 61: Brazil pharmaceuticals market value: $ billion, 2016-21
Figure 62: Brazil pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 63: Brazil pharmaceuticals market share: % share, by value, 2021
Figure 64: Brazil pharmaceuticals market value forecast: $ billion, 2021-26
Figure 65: Forces driving competition in the pharmaceuticals market in Brazil, 2021
Figure 66: Drivers of buyer power in the pharmaceuticals market in Brazil, 2021
Figure 67: Drivers of supplier power in the pharmaceuticals market in Brazil, 2021
Figure 68: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2021
Figure 69: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2021
Figure 70: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2021
Figure 71: Canada pharmaceuticals market value: $ billion, 2016-21
Figure 72: Canada pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 73: Canada pharmaceuticals market share: % share, by value, 2021
Figure 74: Canada pharmaceuticals market value forecast: $ billion, 2021-26
Figure 75: Forces driving competition in the pharmaceuticals market in Canada, 2021
Figure 76: Drivers of buyer power in the pharmaceuticals market in Canada, 2021
Figure 77: Drivers of supplier power in the pharmaceuticals market in Canada, 2021
Figure 78: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2021
Figure 79: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2021
Figure 80: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2021
Figure 81: China pharmaceuticals market value: $ billion, 2016-21
Figure 82: China pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 83: China pharmaceuticals market share: % share, by value, 2021
Figure 84: China pharmaceuticals market value forecast: $ billion, 2021-26
Figure 85: Forces driving competition in the pharmaceuticals market in China, 2021
Figure 86: Drivers of buyer power in the pharmaceuticals market in China, 2021
Figure 87: Drivers of supplier power in the pharmaceuticals market in China, 2021
Figure 88: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2021
Figure 89: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2021
Figure 90: Drivers of degree of rivalry in the pharmaceuticals market in China, 2021